Intralesional HPV Vaccine for Condylomata

Clinical trial NCT05087849 · COMPLETED

Trial details

NCT number: NCT05087849
Sponsor: University of California, San Francisco
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Human Papilloma Virus Warts Warts, Genital Condyloma Condylomata Acuminata

Start date: 2022-04-15
Primary completion: 2024-07-01
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.